KRAS peptide vaccine compositions and method of use
US11771749B2 · kind B2 · utility
0Cited by
5References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 5, 2018 |
| Grant date | Oct 3, 2023 |
| Priority date | — |
| Expiry date | Nov 18, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/86
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides compositions and methods of eliciting an anti-tumor immune response and treating cancer comprising at least one peptide of KRAS.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.